title: Oral lichenoid drug reaction by lithium in a patient with bipolar disorder.
abstract: Bipolar disorder (BD) is a psychiatric disease characterized by recurrent and alternated episodes of depression and mania. For the treatment of BD, anticonvulsants drugs as lithium, carbamazepine and oxcarbazepine can be used. These drugs can be associated with potential adverse effects: weight gain, tremors, thyroid abnormalities, and cognitive, gastrointestinal, cardiac or dermatological problems. We describe a case of BD with oral lichenoid drug reaction probably because of the mood stabilizers.
authors.affiliation: Department of Oral Sciences, University of Palermo, Palermo, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Campisi
authors.forename: A M
authors.initials: AM
authors.lastname: Florena
authors.forename: V
authors.initials: V
authors.lastname: Franco
authors.forename: E
authors.initials: E
authors.lastname: Coccia
authors.forename: L
authors.initials: L
authors.lastname: Lo Muzio
mesh_terms: D018692:Antimanic Agents / Q000009:adverse effects*; D001714:Bipolar Disorder / Q000188:drug therapy; D006801:Humans; D017512:Lichenoid Eruptions / Q000139:chemically induced* / Q000188:drug therapy; D016651:Lithium Carbonate / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D018692:Antimanic Agents; D016651:Lithium Carbonate